Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical significance of RET mutation screening in a pedigree of multiple endocrine neoplasia type 2A.

Molecular medicine reports - 1 Aug 2016

Ying Rongbiao, Feng Jun

Abstract excerpt

The clinical characteristics and RET proto-oncogene (RET‑PO) mutation status of a patient with multiple endocrine neoplasia type 2A pedigree (MEN2A) was analyzed with the aim of preliminarily exploring the molecular mechanisms and clinical significance of the disease. Clinical characteristics of a single MEN2A patient were analyzed. Genomic DNA was extracted from the peripheral blood of the proband and 10 family...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to DNA Mutational Analysis
Share to Follow-Up Studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Multiple Endocrine Neoplasia Type 2a

Share to Proto-Oncogene Mas

Share to Proto-Oncogene Proteins c-ret

Share to Treatment Outcome

Source

Identifiers

PMID: 27277749
DOI: 10.3892/mmr.2016.5371

Genes

RET

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical significance of RET mutation screening in a pedigree of multiple endocrine neoplasia type 2A.PMID 27277749Read ↗

[Clinical features and mutations of RET proto-oncogene in a pedigree affected with type 2A multiple endocrine neoplasia].Semantic proximity Read ↗

Impact of RET proto-oncogene analysis on the clinical management of multiple endocrine neoplasia type 2.Semantic proximity Read ↗

Spectrum of Germline RET Variants Identified by Targeted Sequencing and Associated Multiple Endocrine Neoplasia Type 2 Susceptibility in ChinaSemantic proximity Read ↗

Genetic analysis of a Chinese Han family with multiple endocrine neoplasia type 2A.Semantic proximity Read ↗

RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma.Semantic proximity Read ↗

Nationwide French Study of RET Variants Detected from 2003 to 2013 Suggests a Possible Influence of Polymorphisms as Modifiers.Semantic proximity Read ↗

[A comparison of clinical characteristics between 2 pedigrees of multiple endocrine neoplasia type 2A with different RET mutations].Semantic proximity Read ↗

RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors.Semantic proximity Read ↗

Mendelian genetics of rare—and not so rare—cancersSemantic proximity Read ↗

RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B.Semantic proximity Read ↗

[The clinical patterns and RET proto-oncogene in fifteen multiple endocrine neoplasia type 2A pedigrees].Semantic proximity Read ↗

Lessons from genes mutated in multiple endocrine neoplasia (MEN) syndromes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.